| Literature DB >> 21048850 |
Callinice D Capo-Chichi1, Jennifer L Smedberg, Malgorzata Rula, Emmanuelle Nicolas, Anthony T Yeung, Richard F Adamo, Andrey Frolov, Andrew K Godwin, Xiang-Xi Xu.
Abstract
Background. Mouse embryonic stem (ES) cells can be differentiated in vitro by aggregation and/or retinoic acid (RA) treatment. The principal differentiation lineage in vitro is extraembryonic primitive endoderm. Dab2, Laminin, GATA4, GATA5, and GATA6 are expressed in embryonic primitive endoderm and play critical roles in its lineage commitment. Results. We found that in the absence of GATA4 or GATA5, RA-induced primitive endoderm differentiation of ES cells was reduced. GATA4 (-/-) ES cells express higher level of GATA5, GATA6, and hepatocyte nuclear factor 4 alpha marker of visceral endoderm lineage. GATA5 (-/-) ES cells express higher level of alpha fetoprotein marker of early liver development. GATA6 (-/-) ES cells express higher level of GATA5 as well as mesoderm and cardiomyocyte markers which are collagen III alpha-1 and tropomyosin1 alpha. Thus, deletion of GATA6 precluded endoderm differentiation but promoted mesoderm lineages. Conclusions. GATA4, GATA5, and GATA6 each convey a unique gene expression pattern and influences ES cell differentiation. We showed that ES cells can be directed to avoid differentiating into primitive endoderm and to adopt unique lineages in vitro by modulating GATA factors. The finding offers a potential approach to produce desirable cell types from ES cells, useful for regenerative cell therapy.Entities:
Year: 2010 PMID: 21048850 PMCID: PMC2956456 DOI: 10.4061/2010/602068
Source DB: PubMed Journal: Stem Cells Int Impact factor: 5.443
Figure 6Limited list of genes whose expression is significantly altered following retinoic acid treatment of ES cells grow in monolayer cultures.
| WT | GATA4 | GATA5 | GATA6 | |
|---|---|---|---|---|
|
| 4.38, 3.77 | 2.00, 1.80 | 4.09, 3.24 | 0.05, 0.48 |
| GATA4 | 3.32 | 0.22 | 2.58 | 0.91 |
| GATA6 | 2.04, 2.74, 2.51, 2.38 | 2.15, 2.08 | 1.94 | 0.41, 0.01 |
|
| 2.58, 2.30 | 2.86, 2.73 | 2.94, 2.72 | 2.72, 3.00, 2.84 |
|
| 1.88 | 2.66 | 2.48 | 2.48, 3.03 |
|
| 2.52 | 2.59 | 3.79 | 0.20 |
|
| 2.74, 2.65 | 2.13 | 3.05 | 2.01 |
|
| 2.27, 2.00 | 2.20 | 2.38, 2.94, 2.02 | 2.90 |
|
| 3.20, 3.005, 2.301 | 2.59, 2.2, 2.17 | 2.27, 1.61 | 3.08, 3.05, 2.68, 1.99 |
|
| 0.87 | 0.48 | 1.07 | 3.96 |
|
| 2.55 | 1.76 | 2.90, 2.35 | 0.15, 0.27 |
|
| 2.28, 2.15 | 1.83 | 2.37 | 0.09, 0.65 |
|
| 2.52 | 2.87 | 2.93 | 3.62 |
| fetal liver H19 | 2.20, 2.65, 2.35 | 2.65, 2.38 | 3.86, 3.80, 3.68 | 3.82, 3.80 |
|
| 2.29 | 3.26 | 2.66 | 3.75 |
| mesoderm transcript | 1.29 | 1.77 | 2.09 | 3.12 |
|
| 1.36, 1.37, 1.32 | 2.2, 2.17, 2.1, 1.9 | 1.42, 1.38, 1.35 | 3.68, 3.64, 2.94 |
| alpha fetoprotein | 3.0 | 3.09 | 3.61 | 3.22 |
| POU domain class 5 | 0.66 | 0.00 | −2.01 | −5.18 |
|
| −2.37 | −1.10 | −0.79 | −1.39 |
| Ran small G protein | −2.28 | −0.23 | −0.40 | −1.65 |
The monolayer cultures of ES cells were treated with or without retinoic acid (RA) for 4 days and mRNA was isolated for expression array analysis. A selected list of genes of interest with large-fold expression changes following RA treatment is presented. The fold-changes in expression between with or without RA can be calculated as 2n. The number “n” is listed in the table. Multiple numbers in a category indicate several cDNA entries of the same gene on the cDNA chip. The presence of hybridization signal for a GATA transcript in cells that were homozygous knockout of the GATA gene is likely due to the presence of the mutant GATA transcripts that are inactive. The authors will provide the full data of the expression array experiments if requested. The complete list of differentially expressed genes will be found online: http://www.ncbi.nlm.nih.gov/projects/geo/, Accession “GPL4486”.
Figure 1Endoderm lineage differentiation of ES cells in vitro. Approximately 1 × 106 ES cells of wildtype or deficient in one of GATA factor were seeded on 100 mm plates as a monolayer culture (m) or cultured in suspension to allow cell aggregation to form spheroids (s). The cells were also treated with 1 μM retinoic acid (RA) or DMSO control. Following a 4-day culture period, cell lysates from monolayer (a) or from spheroids (b) were prepared for Western blotting analysis. (c) mRNA was prepared for Northern blot analysis. (d) Preservation of Oct-3/4 protein in embryoid bodies: embryonic stem cells were cultured in medium lacking LIF in suspension to allow the formation of cell aggregates. The embryoid bodies from a 4-day suspension culture were fixed in formalin, embedded in paraffin, sectioned, and immunostained for Oct-3/4 protein. Representative stainings of two embryoid bodies are shown (left panel, 40×, and right panel, 200×).
Figure 2Retinoic acid-induced endoderm differentiation of GATA-deficient ES cells in vitro: ES cells of wildtype, GATA4 (−/−), GATA5 (−/−), or GATA6 (−/−) genotypes in monolayers were treated with or without retinoic acid (1 μM) for 4 days. Cells expressing Dab2 and GATA4 were detected following indirect immunofluorescence staining and counting under fluorescence microscopy. (a) Dab2 (red) and GATA4 (green) were detected under fluorescence microscopy with DAPI (blue) used for nuclear counterstaining. The percentage of Dab2 and GATA4 positive cells was determined by counting an average of 5 fields of cells. (b) The percentages of ES cells expressing GATA4 and Dab2 are presented in histogram. (c) In GATA4 (−/−) the expression of Dab2 correlates with the expression of GATA6. (d) Western blotting showing the absence of endoderm marker Dab2 and expression of mesoderm marker vimentin in GATA6 (−/−) ES cells.
Figure 3Primitive endoderm differentiation and the absence of the basement membrane in GATA5-deficient embryoid bodies. Wildtype and GATA5 (−/−) ES cells were cultured in medium lacking LIF in suspension to allow the formation of cell aggregates on Petri dishes, with or without retinoic acid (1 μM) for 4 days. The embryoid bodies from a 4-day suspension culture were fixed, embedded in paraffin, sectioned, and subjected to PAS staining to detect the basement membrane. Representative stainings are shown (200×). Spheroids of GATA4 (−/−) and GATA6 (−/−) ES cells were previously published [25] and showed that endoderm formation is impaired in GATA4 (−/−) ES cell spheroids without RA. Endoderm formation in GATA4 (−/−) ES cell spheroids can be restored by treatment with RA for 4 days. Spheroid of GATA6 (−/−) ES cells lacked endoderm formation that cannot be restored with RA treatment [25].
Figure 4GATA-binding activity in retinoic acid-induced endoderm differentiation of wildtype and GATA-deficient ES cells. Wild type ES cells and those homozygous deficient in GATA4, GATA5, or GATA6 were treated with retinoic acid (1 μM) for 4 days. Nuclear extracts of the ES cells were used for EMSA and supershifted with antibodies specific for each GATA factor. (a) For EMSA, the labeled Dab2-PI GATA binding probes were incubated with nuclear extracts from ES cells treated with retinoic acid (1 μM) for 4 days. GATA6 (arrow) and GATA4 (arrowhead) containing complexes are indicated. The supershifted GATA4-containing complexes are indicated by a double-arrowhead. (b) GATA6 (−/−) ES cells in monolayers were transfected with GATA4 and immunofluorescence stainings of Dab2 (red) and GATA4 (green) were observed by fluorescence microscopy. DAPI (blue) was used for nuclear counter staining. (c) The binding to the PI probe is compared between nuclear extracts from retinoic acid-treated ES cells and cardiomyocytes. GATA4-containing (arrowhead), anti-GATA4 supershifted (double arrowhead), and GATA6-containing (arrow) complexes are indicated. Self competition (SP) assay was performed with nonradioactive PI probe and nonspecific competitions were performed with m1pI: PI probe with mutation in GATA binding site 1 (lane 6); with m2pI: PI probe with mutation in GATA binding site 2 (lane 7), and m1pI/m2 m2pI: probe PI with mutations in both GATA binding sites (lane 8). αG4 and αG6: antibodies against GATA4 and GATA6; SP: self competition with cold PI; NSP: nonspecific competition.
Information on genes analyzed by real-time RT-PCR using Taqman assay.
| Gene Symbol | NCBI Gene Reference | Target Exons | Context Sequence |
|---|---|---|---|
| Tbp | NM_013684,NM_013684 | 3 | ATCCCAAGCGATTTGCTGCAGTCAT |
| Gata4 | NM_008092,AF179424,U85046, M98339,AB075549 | 3 | CGCCGCCTGTCCGCTTCCCGCCGGG |
| Gata5 | NM_008093,U84725 | 1 | AGGACCAGCTTCGTACCTGACTTCT |
| Gata6 | NM_010258,AF179425 | 5 | CTCAGGGGTAGGGGCATCAGTGATG |
| Dab2 | NM_023118,U18869 | 1 | TAGCTAGTCCGTGTACTTTGTGGGT |
| Pou5f1 | NM_013633,X52437,M34381,BC068268 | 2 | GCGTTCTCTTTGGAAAGGTGTTCAG |
| Afp | NM_007423,V00743,BC066206, AK075972, AK010934,AK076053,AK076197 | 3 | GTGTTTAGAAAGCCAGCTATCTGTG |
| Mest | NM_008590,D16262,AK031718,AK032881,AK034949,BC006639 | 1 | TCGCTTGCGCAGGATGAGAGAGTGG |
| Lpr2 | AF197160,BC040788 | 11 | CTATGCAGAGATGGACACTGAGCAA |
| Hnf4a | NM_008261,D29015,BC039220 | 8 | ATGCTTCTCGGAGGGTCTGCCAGTG |
| Lrp1 | NM_008512,X67469,AF367720 | 15 | CCTGCTTGGCGAACCCATCCTACGT |
| Lama1 | NM_008480,J04064 | 19 | AAACTGCCGAGCCTGTGACTGCCAC |
| Col3a1 | NM_009930,BC058724,M18933,AK029212, BC052398,AK013329,AK041115,AK048546,BC043089 | 4 | GTGGCCAAAATTATTCTCCCCAATT |
| Tdgf1 | NM_011562,M87321 | 15 | AAGACTGGGGAAACAGAGTGGATTG |
| Tpm1 | NM_024427,X64831,M22479,BC026720, AK002271,AK003175,AK032942,AK077713 | 1 | CGGAGCAAGCAGCTGGAAGATGAGC |
| H19 | X58196,BC025150 | 1 | GGACTGGAGACTAGGCCAGGTCTCC |
Tbp was used as normalization control.
Afp: alpha fetal protein; Col3a1: collagen III alpha 1; H19: fetal liver RNA transcript; Lama 1: laminin alpha 1 gene; Lrp: lipoprotein-related receptor protein; Mest: mesoderm-specific transcript; Pou5f1: Oct-3/4; Tdgf1: Teratocarcinoma derived growth factor 1 (cripto); Tbp: TATA box binding protein; Tpm1: tropomyosin 1, alpha.
Figure 5Expression array analysis and verification by quantitative RT-PCR of retinoic acid-induced endoderm differentiation of GATA-deficient ES cells. Wild type embryonic stem cells and those homozygous deficient in GATA4, GATA5, or GATA6 were cultured as monolayers and treated with the DMSO carrier as a control or retinoic acid (1 μM) for 4 days. (a) Representative morphology of the cells with or without retinoic acid. (b) The cells were analyzed by cDNA expression microarray comparing with or without retinoic acid. The results were analyzed by hierarchical clustering. Individual colored rows represent change in expression following retinoic acid treatment of a single gene/sequence tag. Red rows indicate an increase in expression and green rows indicate a decrease in expression, as shown by the color scale bar. (c)–(h) Verification of expression of a panel of selected genes by quantitative RT-PCR Relative gene expression changes with or without retinoic acid in monolayer cells (c) and spheroids (d) are presented as “Heat-Maps”. The figure displays grey scale shades representing the Ct values. Ct (cycle threshold) is the number of PCR cycles at which the fluorescence reaches a significant level above the baseline, given that the higher the starting copy number of the nucleic acid target, the sooner fluorescence increases. The relative levels of a particular transcript between samples can be calculated using the equation: relative quantity = 2 − ∆Ct. The amplification of TBP shows similar amounts of template in all samples. (e)–(h) values that represented relative mRNA levels of the monolayer ES cells are shown and compared. The mRNA values of undifferentiated ES cells are defined as “1” for comparison. The detection of a real-time RT-PCR signal in a specific GATA transcript in the ES cells that were homozygous knockout of that GATA gene is likely due to the presence of transcripts from the mutant/inactive GATA locus.